The Institute of Cancer Research has led a study showing that chromosomal instability in circulating tumour cells can predict resistance to cabazitaxel in men with advanced prostate cancer. Using ...

Don Bryant, Indiana resident, U.S. Army veteran, and prostate cancer survivor who received treatment with Pluvicto™ therapy in clinical trial Philip Low, Purdue Institute for Cancer Research member, ...

Doug pedals fast, feeling the exhilaration of speeding along a bike track as his heart rate rises and he starts to breathe harder. Since being diagnosed with stage 4 metastatic prostate cancer in ...

So far, “the only established risk factors for prostate cancer are advancing age, African ancestry, and a family history of ...

Today, a patient diagnosed with advanced prostate cancer has options. Doctors can offer a suite of androgen-suppressing drugs to extend his life. There are genetic tests that can show whether he’s a ...